A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation

References

• Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K, Trent RJ, Basten A. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 1988; 334:676–682.
   PubMed Web of Science ®Google Scholar
• Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature. 1991; 353:765–769.
   PubMed Web of Science ®Google Scholar
• Nemazee DA, Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature. 1989; 337:562–566.
   PubMed Web of Science ®Google Scholar
• Rubio CF, Kench J, Russell DM, Yawger R, Nemazee D. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes. J Immunol. 1996; 157:65–71.
   PubMedGoogle Scholar
• Rathmell JC, Goodnow CC. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J Immunol. 1994; 153:2831–2842.
   PubMed Web of Science ®Google Scholar
• von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheumat. 1995; 24:323–358.
   PubMed Web of Science ®Google Scholar
• Erikson J, Radic MZ, Camper SA, Hardy RR, Carmack C, Weigert M. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature. 1991; 349:331–334.
   PubMed Web of Science ®Google Scholar
• Chen C, Radic MZ, Erikson J, Camper SA, Litwin S, Hardy RR, Weigert M. Deletion and editing of B cells that express antibodies to DNA. J Immunol. 1994; 152:1970–1982.
   PubMed Web of Science ®Google Scholar
• Pewzner-Jung Y, Friedmann D, Sonoda E, Jung S, Rajewsky K, Eilat D. B cell. deletion, anergy, and receptor editing in “knock in” mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain. J Immunol. 1998; 161:4634–4645.
   PubMedGoogle Scholar
• Santulli-Marotto S, Qian Y, Ferguson S, Clarke SH. Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: Altered differentiation and an accelerated response. J Immunol. 2001; 166:5292–5299.
   PubMedGoogle Scholar
• Borrero M, Clarke SH. Low-affinity anti-Smith antigen B cells are regulated by anergy as opposed to developmental arrest or differentiation to B-1. J Immunol. 2002; 168:13–21.
   PubMedGoogle Scholar
• Benschop RJ, Aviszus K, Zhang X, Manser T, Cambier JC, Wysocki LJ. Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. Immunity. 2001; 14:33–43.
   PubMedGoogle Scholar
• Gauld SB, Benschop RJ, Merrell KT, Cambier JC. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat Immunol. 2005; 6:1160–1167.
   PubMed Web of Science ®Google Scholar
• Conger JD, Pike BL, Nossal GJV. Clonal analysis of the anti-DNA repertoire of murine B lymphocytes. Proc Natl Acad Sci USA. 1987; 84:2931–2935.
   PubMed Web of Science ®Google Scholar
• McHeyzer-Williams MG, Nossal GJV. Clonal analysis of autoantibody-producing cell precursors in the preimmune B cell repertoire. J Immunol. 1988; 141:4118–4123.
   PubMedGoogle Scholar
• Souroujon M, White SM, Andreschwartz J, Gefter ML, Schwartz RS. Preferential autoantibody reactivity of the preimmune B-cell repertoire in normal mice. J Immunol. 1988; 140:4173–4179.
   PubMed Web of Science ®Google Scholar
• Shlomchik MJ, Zharhary D, Saunders T, Camper SA, Weigert MG. A rheumatoid factor transgenic mouse model of autoantibody regulation. Int Immunol. 1993; 5:1329–1341.
   PubMed Web of Science ®Google Scholar
• Hannum LG, Ni D, Haberman AM, Weigert MG, Shlomchik MJ. A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: Implications for the origins of autoantibodies in autoimmune disease. J Exp Med. 1996; 184:1269–1278.
   PubMed Web of Science ®Google Scholar
• William J, Euler C, Christensen S, Shlomchik MJ. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science. 2002; 297:2066–2070.
   PubMed Web of Science ®Google Scholar
• William J, Euler C, Leadbetter E, Marshak-Rothstein A, Shlomchik MJ. Visualizing the onset and evolution of an autoantibody response in systemic autoimmunity. J Immunol. 2005; 174:6872–6878.
   PubMedGoogle Scholar
• William J, Euler C, Shlomchik MJ. Short-lived plasmablasts dominate the early spontaneous rheumatoid factor response: Differentiation pathways, hypermutating cell types, and affinity maturation outside the germinal center. J Immunol. 2005; 174:6879–6887.
   PubMedGoogle Scholar
• Herlands RA, William J, Hershberg U, Shlomchik MJ. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. Eur J Immunol. 2007; 37:3339–3351.
   PubMed Web of Science ®Google Scholar
• Herlands RA, Christensen SR, Sweet RA, Hershberg U, Shlomchik MJ. T-cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity. 2008; 29:249–260.
   PubMed Web of Science ®Google Scholar
• Khan SN, Witsch EJ, Goodman NG, Panigrahi AK, Chen C, Jiang Y, Cline AM, Erikson J, Weigert M, Prak ETL, Radic M. Editing and escape from editing in anti-DNA B cells. Proc Natl Acad Sci USA. 2008; 105:3861–3866.
   PubMedGoogle Scholar
• Li Y, Louzoun Y, Weigert M. Editing Anti-DNA B cells by V{lambda}x. J Exp Med. 2004; 199:337–346.
   PubMedGoogle Scholar
• Li Y, Li H, Weigert M, Autoreactive B. cells in the marginal zone that express dual receptors. J Exp Med. 2002; 195:181–188.
   PubMed Web of Science ®Google Scholar
• Li H, Jiang Y, Prak EL, Radic M, Weigert M. Editors and editing of anti-DNA receptors. Immunity. 2001; 15:947–957.
   PubMedGoogle Scholar
• Tsao PY, Jiao J, Ji MQ, Cohen PL, Eisenberg RA. T-cell-independent spontaneous loss of tolerance by anti-double-stranded DNA B cells in C57BL/6 mice. J Immunol. 2008; 181:7770–7777.
   PubMed Web of Science ®Google Scholar
• Sekiguchi DR, Jainandunsing SM, Fields ML, Maldonado MA, Madaio MP, Erikson J, Weigert M, Eisenberg RA. Chronic graft-versus-host in Ig Knockin transgenic mice abrogates B-cell tolerance in anti-double-stranded DNA B Cells. J Immunol. 2002; 168:4142–4153.
   PubMedGoogle Scholar
• Sekiguchi DR, Eisenberg RA, Weigert M. Secondary heavy chain rearrangement: A mechanism for generating anti-double-stranded DNA B cells. J Exp Med. 2003; 197 1: 27–39.
   PubMedGoogle Scholar
• Ehlers M, Fukuyama H, McGaha TL, Aderem A, Ravetch JV. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med. 2006; 203 3: 553–561.
   PubMed Web of Science ®Google Scholar
• Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000; 102:553–563.
   PubMed Web of Science ®Google Scholar
• Green NM, Laws A, Kiefer K, Busconi L, Kim YM, Brinkmann MM, Trail EH, Yasuda K, Christensen SR, Shlomchik MJ, Vogel S, Connor JH, Ploegh H, Eilat D, Rifkin IR, van Seventer JM, Marshak-Rothstein A. Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop. J Immunol. 2009; 183:1569–1576.
   PubMed Web of Science ®Google Scholar
• Uccellini MB, Busconi L, Green NM, Busto P, Christensen SR, Shlomchik MJ, Marshak-Rothstein A, Viglianti GA, Autoreactive B. cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha. J Immunol. 2008; 181:5875–5884.
   PubMed Web of Science ®Google Scholar
• Chen C, Nagy Z, Prak EL, Weigert M. Immunoglobulin heavy chain gene replacement: A mechanism of receptor editing. Immunity. 1995; 3:747–755.
   PubMedGoogle Scholar
• Wang H, Shlomchik MJ. Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J Exp Med. 1999; 190:639–649.
   PubMed Web of Science ®Google Scholar
• Losman MJ, Fasy TM, Novick KE, Monestier M. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp( − )+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. J Immunol. 1992; 148:1561–1569.
   PubMed Web of Science ®Google Scholar
• William J, Euler C, Primarolo N, Shlomchik MJ.. B cell tolerance checkpoints that restrict pathways of antigen-driven differentiation. J Immunol. 2006; 176:2142–2151.
   PubMed Web of Science ®Google Scholar
• Martin F, Kearney JF.. B cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory”. Immunol Rev. 2000; 175:70–79.
   PubMed Web of Science ®Google Scholar
• Martin F, Kearney JF. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity. 2000; 12:39–49.
   PubMed Web of Science ®Google Scholar
• Martin F, Chen X, Kearney JF. Development of VH81X transgene-bearing B cells in fetus and adult: Sites for expansion and deletion in conventional and CD5/B1. Int Immunol. 1997; 9:493–505.
   PubMedGoogle Scholar
• Chen X, Martin F, Forbush KA, Perlmutter RM, Kearney JF. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol. 1997; 9:27–41.
   PubMedGoogle Scholar
• Chumley MJ, Dal Porto JM, Kawaguchi S, Cambier JC, Nemazee D, Hardy RR. A VH11V kappa 9 B cell antigen receptor drives generation of CD5+B cells both in vivo and in vitro. J Immunol. 2000; 164:4586–4593.
   PubMedGoogle Scholar
• Tatu C, Ye J, Arnold LW, Clarke SH. Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity. J Exp Med. 1999; 190:903–914.
   PubMedGoogle Scholar
• Vinuesa CG, Sanz I, Cook MC. Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol. 2009; 9:845–857.
   PubMed Web of Science ®Google Scholar
• Pape KA, Kouskoff V, Nemazee D, Tang HL, Cyster JG, Tze LE, Hippen KL, Behrens TW, Jenkins MK. Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J Exp Med. 2003; 197:1677–1687.
   PubMed Web of Science ®Google Scholar
• MacLennan ICM, Toellner K-M, Cunningham AF, Serre K, Sze DMY, Zuniga E, Cook MC, Vinuesa CG. Extrafollicular antibody responses. Immunol Rev. 2003; 194:8–18.
   PubMed Web of Science ®Google Scholar
• Cunningham AF, Gaspal F, Serre K, Mohr E, Henderson IR, Scott-Tucker A, Kenny SM, Khan M, Toellner KM, Lane PJ, MacLennan IC. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J Immunol. 2007; 178:6200–6207.
   PubMed Web of Science ®Google Scholar
• Jacobson BA, Panka DJ, Nguyen KA, Erikson J, Abbas AK, Marshak-Rothstein A. Anatomy of autoantibody production: Dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity. 1995; 3:509–519.
   PubMedGoogle Scholar
• Jacobson BA, Rothstein TL, Marshak-Rothstein A. Unique site of IgG2a and rheumatoid factor production in MRL/lpr mice. Immunol Rev. 1997; 156:103–110.
   PubMedGoogle Scholar
• Mandik-Nayak L, Seo SJ, Sokol C, Potts KM, Bui A, Erikson J. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J Exp Med. 1999; 189:1799–1814.
   PubMedGoogle Scholar
• Eaton-Bassiri AS, Mandik-Nayak L, Seo SJ, Madaio MP, Cancro MP, Erikson J. Alterations in splenic architecture and the localization of anti-double- stranded DNA B cells in aged mice. Int Immunol. 2000; 12:915–926.
   PubMedGoogle Scholar
• Hoyer BF, Moser K, Hauser AE, Peddinghaus A, Voigt C, Eilat D, Radbruch A, Hiepe F, Manz RA. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med. 2004; 199:1577–1584.
   PubMed Web of Science ®Google Scholar
• Cambridge G, Leandro MJ, Edwards JC, Ehrenstein MR, Salden M, Bodman-Smith M, Webster AD. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum. 2003; 48:2146–2154.
   PubMed Web of Science ®Google Scholar
• Sfikakis PP, Boletis JN, Tsokos GC. Rituximab anti-B-cell therapy in systemic lupus erythematosus: Pointing to the future. Curr Opin Rheumatol. 2005; 17:550–557.
   PubMed Web of Science ®Google Scholar
• Ferraro AJ, Drayson MT, Savage CO, MacLennan IC. Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab. Eur J Immunol. 2008; 38:292–298.
   PubMedGoogle Scholar
• Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ, Smyth MJ, Mackay CR, Mackay F. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med. 2007; 204:1959–1971.
   PubMed Web of Science ®Google Scholar
• Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006; 25:417–428.
   PubMed Web of Science ®Google Scholar
• Meyer-Bahlburg A, Khim S, Rawlings D, B cell intrinsic TLR. signals amplify but are not required for humoral immunity. J Exp Med. 2007; 204:3095–3101.
   PubMed Web of Science ®Google Scholar
• Barr TA, Brown S, Mastroeni P, Gray DJ. B cell intrinsic MyD88 signals drive IFN-gamma production from T cells and control switching to IgG2c. J Immunol. 2009; 183:1005–1012.
   PubMed Web of Science ®Google Scholar
• Eckl-Dorna J, Batista FD. BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation. Blood. 2009; 113:3969–3977.
   PubMed Web of Science ®Google Scholar